Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Leading Players in the North America Glioma Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Pfizer Inc.
This leading research-based global biopharmaceutical company invests a substantial portion of its total R&D budget in the area of oncology and is actively involved in the clinical development of glioma drugs.
Novartis AG
This Swiss multinational pharmaceutical company has a prominent presence in the market. Its FDA-approved Tafinlar + Mekinist is indicated for pediatric patients with BRAF V600E low-grade glioma.
Johnson & Johnson
Johnson & Johnson, an American multinational, pharmaceutical, and medical technologies company, is engaged in merger and acquisition activities to expand its market presence. It is also involved in the research and development of innovative glioma treatments.
Merck & Co., Inc.
Merck & Co., Inc., a leading science and technology company, leverages strategic collaborations to accelerate the market entry of cancer drug candidates and develops prescription products related to the treatment of brain tumors.
Other players in the market include Roche Holding AG, Bristol-Myers Squibb Company, Amgen Inc., AstraZeneca PLC, Eli Lilly and Company, and AbbVie Inc.
North America Glioma Market Report Snapshots
North America Glioma Market Size
North America Glioma Market Analysis
North America Glioma Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The North America glioma market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 3.22% during the forecast period of 2024-2032 and is likely to reach a market value of USD 1.3 billion by 2032.
The rising prevalence of glioma along with the growing aging population is fuelling the demand for the market.
One of the significant trends in the market is the increased approval of advanced glioma therapies. For instance, in February 2024, Servier Pharmaceuticals LLC’s vorasidenib (AG-881) new drug application was accepted and granted priority review by the FDA for the treatment of patients with IDH-mutant diffuse glioma.
Based on the type, the market is segmented into astrocytoma, oligodendroglioma, and glioblastoma.
By diagnosis, the market is divided into angiograms, magnetic resonance imaging (MRI), computerized tomography (CT), and surgical biopsy, among others.
The market breakup by treatment type includes chemotherapy, radiation, and surgery.
The market breakup by route of administration includes oral and parenteral.
The market segmentation by countries includes the United States and Canada.
The key players in the market are Pfizer Inc., Novartis AG, Johnson & Johnson, Merck & Co., Inc., Roche Holding AG, Bristol-Myers Squibb Company, Amgen Inc., AstraZeneca PLC, Eli Lilly and Company, and AbbVie Inc.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124